The short answer
SEER reports a 52.0% five-year relative survival rate for ovarian cancer overall. Localized ovarian cancer is 91.9%; distant (metastatic) disease is 31.5%. Ovarian cancer is often found late because early symptoms are vague, and BRCA and other genetic testing increasingly shapes treatment.
A survival statistic describes a large group diagnosed years ago — not a prediction for any one person.
For ovarian cancer, the five-year relative survival rate for everyone combined, diagnosed 2016–2022, was 52.0%.
Stage at diagnosis makes a large difference: localized disease is 91.9% versus 31.5% for distant (metastatic) disease.
BRCA1/BRCA2 testing is now standard in ovarian cancer care and can open up PARP inhibitor treatment.
Choose how you want to understand this
The full explanation.
Before you look at the numbers
Three things are true about the numbers below. Please read all three before you look at a single ovarian cancer percentage.
First, a "5-year relative survival rate" for ovarian cancer describes a large group of people. Those people were diagnosed with ovarian cancer years ago. It is not a prediction about you. Everyone's ovarian cancer, body, and treatment plan are different.
Second, this data lags behind today's care. These figures reflect people diagnosed with ovarian cancer between 2016 and 2022. Targeted drugs called PARP inhibitors have become more widely used since then, especially for BRCA-related ovarian cancer. So ovarian cancer treatment today may already work better than these numbers suggest.
Third, an all-stages ovarian cancer number blends two very different groups. It mixes people whose ovarian cancer was found early. It also counts people whose ovarian cancer had already spread. For ovarian cancer, the stage-specific numbers below beat one blended average. And "5-year" is just a measuring window, not a ovarian cancer milestone. It is not a life expectancy for anyone with ovarian cancer. It is not a deadline either.
The SEER numbers for ovarian cancer
SEER's most recent report covers people diagnosed with ovarian cancer between 2016 and 2022. Across every stage combined, the five-year relative survival rate was 52.0%. The earlier ovarian cancer is caught, the better the outlook. But ovarian cancer is often found only after it has already spread.
About 1 in 5 ovarian cancers are found at the localized stage. Over half are found only after the cancer has spread widely, at the distant stage.
| Stage at diagnosis | 5-year relative survival |
|---|---|
| Localized — confined to the ovary | 91.9% |
| Regional — spread to nearby lymph nodes | 70.1% |
| Distant — spread to other parts of the body | 31.5% |
| Unknown/unstaged | 38.5% |
What "relative survival" actually means
Relative survival compares two groups. One group has ovarian cancer. The other group is the same age and sex, but has no ovarian cancer. Say the rate is 100%. That would mean the ovarian cancer group was as likely to reach 5 years as the other. It is not the share of people who are free of ovarian cancer. It is not the share of people who die from ovarian cancer itself.
Ovarian cancer often causes vague symptoms, such as bloating or feeling full quickly. Those are easy to mistake for something less serious. BRCA1 and BRCA2 genetic testing is now a standard part of ovarian cancer care. It can pick out people who may benefit from PARP inhibitor drugs. It can also change what family members learn about their own cancer risk.
What actually changes your outlook
A statistic describes a group. Your outlook depends on things specific to you.
- Stage — how far the ovarian cancer has spread, as shown in the table above.
- Grade — how odd the ovarian cancer cells look, and how fast they tend to grow.
- BRCA1/BRCA2 status — genetic testing that can open up PARP inhibitor treatment. It also shapes family risk counseling.
- Histologic subtype — high-grade serous ovarian cancer, the most common subtype, behaves differently from rarer subtypes.
- How your ovarian cancer responds — early scans and labs often say more than the first numbers.
- Your overall health — other health problems, age, and fitness shape ovarian cancer treatment and recovery.
- Access to care — a quick ovarian cancer diagnosis, specialist care, and finishing treatment all matter.
Questions for your care team
- Which SEER stage describes my ovarian cancer, and what is its five-year number?
- Which biomarkers or molecular tests matter in ovarian cancer, and were they run on my sample?
- How do my age and overall health change these ovarian cancer statistics for me?
- Are there newer ovarian cancer treatments available now that this data doesn't reflect yet?
- Beyond the general ovarian cancer statistics, what does my team expect in my case?
- Where can I find support for how it feels to hear these ovarian cancer numbers?
- Has my tumor or blood been tested for a BRCA1 or BRCA2 mutation, and does that open up any treatment options?
If these numbers are hard to sit with
Ovarian cancer numbers can leave you scared, numb, or overwhelmed. That is normal. It does not mean you are handling a ovarian cancer diagnosis the wrong way. Many people take these ovarian cancer numbers in slowly, or with someone in the room. Others skip the numbers until they feel ready. Cancer Anxiety and Uncertainty covers the fear these ovarian cancer numbers can stir up. It is also worth telling your ovarian cancer team how much detail you want, and when.
Sources
Words to know
Tap any term to see what it means.
Common questions
What does 52.0% five-year relative survival mean for ovarian cancer?
It means that, on average, people diagnosed with ovarian cancer between 2016 and 2022 were about 52.0% as likely to be alive 5 years later as people of the same age and sex without ovarian cancer. It blends every stage together, from early to advanced.
Why is the stage-specific number so different from the overall number?
The overall number blends people found early, when ovarian cancer is most treatable, with people found later. Stage makes a large difference — see the table above. Localized ovarian cancer usually has a much higher five-year relative survival than distant (metastatic) disease.
Does this number predict what will happen to me?
No. This is a statistic about a large group of people, not a prediction about you. Your age, overall health, tumor biology, and how your ovarian cancer responds to treatment all shape your individual outlook in ways a group statistic cannot capture.
Is this the most current data available?
It is the most recent data SEER has published, but it still reflects people diagnosed in 2016–2022. Treatments keep changing, so people diagnosed today may do better than these numbers suggest.
Why is there no reliable screening test for ovarian cancer?
Unlike cervical cancer, there is no test proven to reliably screen for ovarian cancer in people at average risk. This is a major reason ovarian cancer is often found late. People with a strong family history or a BRCA mutation may be offered closer monitoring or risk-reducing options, which is worth discussing with your care team.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Last updated: 2026-08-17Next planned review: 2027-08-03
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share